Announcement

CCHE Seminar Series: Economic Evaluation of Rehabilitation Technologies: What are the Unique Challenges We Face?

Economic Evaluation of Rehabilitation Technologies: What are the Unique Challenges We Face?

Brian Chan

KITE – Toronto Rehabilitation Institute and University of Toronto

Friday February 10, 2023, 10am-12pm, HSB 108 and Zoom

Abstract: With a progressively aging population there is an increasing need for health care technologies that address the growing demand for rehabilitation.  A greater number of health technology assessments (including economic evaluations) of rehabilitation technologies are required to assist health care decision-makers in determining which technologies should be implemented in a health care system.  It is unclear what the current landscape is on the economic evaluation of rehabilitation technologies.  Also it is unknown whether these types of interventions have specific characteristics that make it difficult to develop an economic evaluation.  In this interactive discussion, I will be reviewing the difficulties with conducting economic evaluation of medical devices and reflecting on whether these barriers are applicable to rehabilitation technologies.  Most of the topics discussed are a part of ongoing work so your feedback would be greatly appreciated.

Brian is an Affiliate Scientist with the Neural Engineering and Therapeutics Team at KITE – Toronto Rehabilitation Institute and an Assistant Professor at the Institute of Health Policy, Management and Evaluation at the University of Toronto. His research focuses on economic analyses and health technology assessment for individuals requiring rehabilitation including spinal cord injury and dementia.  The goal is to provide evidence that will inform the development of technologies that can improve health.  Current projects include evaluating the evidence for the cost effectiveness of telerehabilitation technologies, developing a framework for evaluating assistive technologies for dementia and understanding the economics of activity based therapies